Dermatological Toxicities of Bruton’s Tyrosine Kinase Inhibitors
V. Sibaud, M. Beylot‐Barry, Caroline Protin, Émmanuelle Vigarios, Christian Récher, Loïc Ysebaert
Topics & Concepts
Bruton's tyrosine kinaseIbrutinibMedicineTyrosine kinaseCancer researchImmunologyChronic lymphocytic leukemiaPharmacologyLeukemiaInternal medicineReceptorChronic Lymphocytic Leukemia ResearchImmunodeficiency and Autoimmune DisordersLymphoma Diagnosis and Treatment